SIGA Technologies Inc (SIGA)
6.44
+0.17
(+2.71%)
USD |
NASDAQ |
Nov 22, 15:51
SIGA Technologies Revenue (Quarterly): 10.01M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 10.01M |
June 30, 2024 | 21.81M |
March 31, 2024 | 25.43M |
December 31, 2023 | 116.48M |
September 30, 2023 | 9.235M |
June 30, 2023 | 5.878M |
March 31, 2023 | 8.323M |
December 31, 2022 | 11.36M |
September 30, 2022 | 72.21M |
June 30, 2022 | 16.67M |
March 31, 2022 | 10.54M |
December 31, 2021 | 115.36M |
September 30, 2021 | 4.846M |
June 30, 2021 | 8.653M |
March 31, 2021 | 4.814M |
December 31, 2020 | 37.73M |
September 30, 2020 | 44.26M |
June 30, 2020 | 40.35M |
March 31, 2020 | 2.620M |
December 31, 2019 | 4.264M |
September 30, 2019 | 8.111M |
June 30, 2019 | 3.908M |
March 31, 2019 | 10.46M |
December 31, 2018 | 1.569M |
September 30, 2018 | 471.08M |
Date | Value |
---|---|
June 30, 2018 | 2.661M |
March 31, 2018 | 1.748M |
December 31, 2017 | 1.412M |
September 30, 2017 | 1.390M |
June 30, 2017 | 4.265M |
March 31, 2017 | 5.202M |
December 31, 2016 | 7.158M |
September 30, 2016 | 4.658M |
June 30, 2016 | 1.901M |
March 31, 2016 | 1.270M |
December 31, 2015 | 4.189M |
September 30, 2015 | 1.327M |
June 30, 2015 | 1.468M |
March 31, 2015 | 1.192M |
December 31, 2014 | 0.8404M |
September 30, 2014 | 1.099M |
June 30, 2014 | 0.6506M |
March 31, 2014 | 0.5494M |
December 31, 2013 | 0.9341M |
September 30, 2013 | 2.292M |
June 30, 2013 | 0.9647M |
March 31, 2013 | 1.328M |
December 31, 2012 | 2.514M |
September 30, 2012 | 2.290M |
June 30, 2012 | 2.701M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.620M
Minimum
Mar 2020
116.48M
Maximum
Dec 2023
28.54M
Average
10.95M
Median
Revenue (Quarterly) Benchmarks
Emergent BioSolutions Inc | 283.80M |
Geovax Labs Inc | 2.790M |
Abbott Laboratories | 10.64B |
Tonix Pharmaceuticals Holding Corp | 2.822M |
Chimerix Inc | 0.026M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 1.344M |
Total Expenses (Quarterly) | 9.468M |
EPS Diluted (Quarterly) | 0.02 |
Enterprise Value | 348.44M |
Gross Profit Margin (Quarterly) | 53.59% |
Profit Margin (Quarterly) | 13.43% |
Earnings Yield | 18.63% |
Operating Earnings Yield | 22.60% |
Normalized Earnings Yield | 18.63 |